Identification and characterization of the retinoic acid response elements in the human RIG1 gene promoter

Biochemical and Biophysical Research Communications

Volumn 331, Issue 2, 2005, Pages 630-639

  Jiang, Shun Yuan ^a   Wu, Meng Shiun ^a   Chen, Liang Ming ^a   Hung, Mei Whey ^b   Lin, Huai En ^a   Chang, Gu Gang ^a   Chang, Tsu Chung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

All trans retinoic acid; Class II tumor suppressor gene; Retinoic acid response elements; RIG1 gene

Indexed keywords

LUCIFERASE; NUCLEOTIDE; RETINOIC ACID; RETINOIC ACID INDUCED GENE 1 PROTEIN; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CELL LINE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; EXTRACT; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; GENETIC TRANSFECTION; GENOMIC FRAGMENT; HUMAN; HUMAN CELL; INVERTED REPEAT; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR BINDING; STOMACH CANCER; TRANSACTIVATION; TRANSLATION INITIATION; TUMOR SUPPRESSOR GENE;

ATRA;

EID: 18044368283     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.214     Document Type: Article

References (32)

1. D. DiSepio, C. Ghosn, R.L. Eckert, A. Deucher, N. Robinson, M. Duvic, R.A.S. Chandraratna, and S. Nagpal Identification and characterization of a retinoid-induced class II tumor suppressor growth regulatory gene Proc. Natl. Acad. Sci. USA 95 1998 14811 14815
2. S.L. Huang, R.Y. Shyu, M.Y. Yeh, and S.Y. Jiang Cloning and characterization of a novel retinoid-inducible gene 1 (RIG 1) deriving from human gastric cancer cells Mol. Cell. Endocrinol. 159 2000 15 24
3. A. Hajnal, R. Klemenz, and R. Schafer Subtraction cloning of H-re6 107, a gene specifically expressed in H-ras resistant fibroblasts Oncogene 9 1994 479 490
4. C. Sers, K. Husmann, I. Nazarenko, S. Reich, K. Wiechen, B. Zhumabayeva, P. Adhikari, K. Schroder, A. Gontarewicz, and R. Schafer The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells Oncogene 21 2002 2829 2839
5. H. Akiyama, Y. Hiraki, M. Noda, C. Shigeno, H. Ito, and T. Nakamura Molecular cloning and biological activity of a novel Ha-Ras suppressor gene predominantly expressed in skeletal muscle, heart, brain, and bone marrow by differential display using clonal mouse EC cells, ATDC5 J. Biol. Chem. 274 1999 32192 32197
6. R.-Y. Shyu, D.-Y. Lin, U. Reichert, and S.-Y. Jiang The synthetic retinoid CD437 induces cell... cycle arrest by differential regulation of cell cycle associated proteins Anticancer Res. 22 2002 2757 2764
7. A. Deucher, S. Nagpal, R.A. Chandraratna, D. Di Sepio, N.A. Robinson, S.R. Dashti, and R.L. Eckert The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity Int. J. Oncol. 17 2000 1195 1203
8. B. Casanova, M.T. de la Fuente, M. Garcia-Gila, L. Sanz, A. Silva, J.A. Garcia-Marco, and A. Garcia-Pardo The class II tumor-suppressor gene RARRES3 is expressed in B cell lymphocytic leukemias and down-regulated with disease progression Leukemia 15 2001 1521 1526
9. M. Duvic, X. Ni, R. Talpur, K. Herne, C. Schulz, D. Sui, S. Ward, A. Joseph, and P. Hazarika Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application J. Invest. Dermatol. 121 2003 902 909
10. R.-Y. Shyu, S.-Y. Jiang, J.-M. Chou, Y.-L. Shih, M.-S. Lee, J.-C. Yu, P.-C. Chao, Y.-J. Hsu, and S.-W. Jao RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma Br. J. Cancer 89 2003 146 151
11. S.-Y. Jiang, J.-M. Chou, F.-J. Leu, Y.-Y. Hsu, Y.-L. Shih, J.-C. Yu, M.-S. Lee, and R.-Y. Shyu Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma World J. Gastroenterol. 11 2005 948 953
12. M.T. Sturniolo, S.R. Dashti, A. Deucher, E.A. Rorke, A.M. Broome, R.A. Chandraratna, T. Keepers, and R.L. Eckert A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase J. Biol. Chem. 278 2003 48066 48073
13. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, and P. Chambon The nuclear receptor superfamily: the second decade Cell 83 1995 835 839
14. A. Aranda, and A. Pascual Nuclear hormone receptors and gene expression Physiol. Rev. 81 2001 1269 1304
15. P. Chambon A decade of molecular biology of retinoic acid receptors FASEB J. 10 1996 940 954
16. R. Kurokawa, M. Soderstrom, A. Horlein, S. Halachmi, M. Brown, M.G. Rosenfeld, and C.K. Glass Polarity-specific activities of retinoic acid receptors determined by a co-repressor Nature 377 1995 451 454
17. C.C. Tzeng, C.L. Meng, L. Jin, and H.F. Hsieh Cytogenetic studies of gastric adenocarcinoma Cancer Genet. Cytogenet. 55 1991 67 71
18. M.W. Hung, L.C. Tsai, Y.L. Lin, Y.H. Chen, G.G. Chang, and T.C. Chang Differential regulation of placental and germ cell alkaline phosphatases by glucocorticoid and sodium butyrate in human gastric carcinoma cell line TMK-1 Arch. Biochem. Biophys. 388 2001 45 54
19. T.C. Chang, A.M. Nardulli, D. Lew, and D.J. Shapiro The role of estrogen response elements in expression of the Xenopus laevis Vitellogenin Bl gene Mol. Endocrinol. 6 1992 346 354
20. K. Roder, M.-J. Latasa, and H.S. Sul Transcriptional regulation of the mouse H-rev107 gene encoding a class II tumor suppressor by CpG methylation J. Biol. Chem. 277 2002 30543 30550
21. W.J. Krzyzosiak, N. Shindookada, H. Teshima, K. Nakajima, and S. Nishimura Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH-3T3 cells by treatment with azatyrosine Proc. Natl. Acad. Sci. USA 89 1992 4879 4883
22. F. Acquati, C. Morelli, R. Cinquetti, M.G. Bianchi, D. Porrini, L. Varesco, V. Gismondi, R. Rocchetti, S. Talevi, L. Possati, C. Magnanini, M.G. Tibiletti, B. Bernasconi, M.G. Daidon, V. Shridhar, D.I. Smith, M. Negrini, G. Barbanti-Brodano, and R. Taramelli Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 Oncogene 20 2001 980 988
23. E. Higuchi, R.A. Chandraratna, W.K. Hong, and R. Lotan Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype Oncogene 22 2003 4627 4635
24. b gene is activated by the RAR/RXR heterodimer Nucleic Acids Res. 24 1996 694 701
25. M. Larose, A.-M. Cassard-Doulcier, C. Fleury, F. Serrai, O. Champigny, F. Bouillaud, and D. Ricquie Essential cis-acting elements in rat uncoupling protein gene are in an enhancer containing a complex retinoic acid response domain J. Biol. Chem. 271 1996 31533 31542
26. C.H. Lee, and L.N. Wei Characterization of an inverted repeat with a zero spacer (IR0)-type retinoic acid response element from the mouse nuclear orphan receptor TR2-11 gene Biochemistry 38 1999 8820 8825
27. S. Kato, H. Sasaki, M. Suzawa, S. Masushige, L. Tora, P. Chambon, and H. Gronemeyer Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors Mol. Cell. Biol. 15 1995 5858 5867
28. W. Xie, and R.M. Evans Orphan nuclear receptors: the exotics of xenobiotics J. Biol. Chem. 276 2001 37739 37742
29. A. Bist, C.J. Fielding, and P.E. Fielding p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism Biochemistry 39 2000 1966 1972
30. Z. Zou, C. Gao, A.K. Nagaich, T. Connell, S. Saito, J.W. Moul, P. Seth, E. Appella, and S. Srivastava p53 regulates the expression of the tumor suppressor gene maspin J Biol. Chem. 275 2000 6051 6054
31. H. Shimada, T.L. Liu, T. Ochiai, T. Shimizu, Y. Haup, H. Hamada, T. Abe, M. Oka, M. Takiguchi, and T. Hiwasa Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells Oncogene 21 2003 1208 2016
32. G.D. Grossfeld, D.A. Ginsberg, J.P. Stein, B.H. Bochner, D. Esrig, S. Groshen, M. Dunn, P.W. Nichols, C.R. Taylor, D.G. Skinner, and R.J. Cote Thrombospondin-1 expression in bladder cancer: association with p53 alteration, tumor angiogenesis, and tumor progression J. Natl. Cancer Inst. 89 1997 219 227